Theme editorial| Volume 18, ISSUE 4, P613-620, December 1997

Making Landsteiner's discovery superfluous: Safety and economic implications of a universal group O red blood cell supply

      This paper is only available as a PDF. To read, Please Download here.


      The risks of ABO-mediated acute immune hemolytic transfusion reactions continue to bedevil modern transfusion services. Of particular concern, the incidence of transfusion fatalities has not changed over time, in stark comparison to the fall in risks of infectious diseases. This article reviews the approaches employed to combat aspects of ABO transfusion errors. The advantages of a universal group O donor pool are considered, and some innovative approaches for achieving this goal, including enzymatic modification of the red cell membrane, the epitope masking through the use of polyethylene glycol, are described. The impact of a group O blood supply on transfusion practices, and on costs to healthcare system, are considered.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Springer GF
        Importance of blood-group substances in interactions between man and microbes.
        Ann NY Acad Sci. 1970; 169: 134-152
        • Honig CL
        • Bove JR
        Transfusion-associated fatalities: Review of Bureau of Biologics reports.
        Transfusion. 1980; 20: 653-661
        • Sazama K
        Reports of 355 transfusion-associated deaths: 1976 through 1985.
        Transfusion. 1990; 30: 583-590
        • Kessler DA
        Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems.
        J Am Med Assoc. 1993; 269: 2765-2768
        • Linden JV
        • Paul B
        • Dressler KP
        A report of 104 transfusion errors in New York State.
        Transfusion. 1992; 32: 601-606
        • Baele PL
        • De Bruyere M
        • Deneys V
        Bedside transfusion errors.
        in: A prospective study by the Belgium SAnGUIS group. Vox Sang. 66. 1994: 117-121
        • Renner SW
        • Howanitz PJ
        • Bachner P
        Wristband identification error reporting in 712 hospitals.
        in: A College of American Pathologistsl Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med. 117. 1993: 571-577
      1. Lumadue JA, Boyd JS, Ness PM. Adherence to a strict specimen labeling policy decreases the incidence of erroneous blood grouping in blood bank specimens. Transfusion, in press.

        • Pineda AA
        • Brzica SM
        • Taswell HF
        Hemolytic transfusion reaction.
        in: Recent experience in a large blood bank. Mayo Clin Proc. 53. 1978: 378-390
        • Wenz B
        • Burns ER
        Improvement in transfusion safety using a new blood unit and patient identification system as part of safe transfusion practice.
        Transfusion. 1991; 31: 401-403
        • Goldstein J
        Conversion of ABO blood groups.
        Transf Med Rev. 1989; 3: 206-212
        • Dybus S
        • Aminoff D
        Action of alphagalactosidase from Clostridium sporogenes and coffee beans on blood group B antigen of erythrocytes.
        Transfusion. 1983; 23: 244-247
        • Goldstein J
        Preparation of transfusable red cells by enzymatic conversion.
        Prog Clin Biol Res. 1984; 165: 139-157
        • Lenny LL
        • Hurst R
        • Goldstein J
        • Benjamin LJ
        • Jones RL
        Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers.
        Blood. 1991; 77: 1383-1388
        • Lenny LL
        • Hurst R
        • Zhu A
        • Goldstein J
        • Galbraith RA
        Multiple-unit and second transfusions of red cells enzymatically converted from group B to group 0: report on the end of Phase I trials.
        Transfusion. 1995; 35: 899-902
        • Hoskins LC
        • Larson G
        • Naff GB
        Blood group A immunodeterminants on human red cells differ in biologic activity and sensitivity to alpha-N- acetylgalactosaminidase.
        Transfusion. 1995; 35: 813-821
        • Murad K
        • Koumpouras F
        • Talbot M
        • Eaton JW
        • Scott MD
        Molecular camouflage of antigenic determinants on intact mammalian cells: possible applications to transfusion medicine.
        Blood (Abstract). 1996; 88: 444a
        • Hortin GL
        • Huang ST
        Surface-pegylated red cells as potential universal donor red cells.
        Blood. 1996; 88: 181a
        • Aubuchon P
        • Littenberg B
        A costeffectiveness analysis of the use of a barrier system to reduce the risk of mistransfusion.
        Transfusion. 1996; 36: 222-226